(Post-pandemic Era)-Global Contrast Agents Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027

Report Code : XYZ2439038
Published On: Apr, 2021
Category : Chemicals & Materials
Pages : 106

As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Research published a report for global Contrast Agents market in this environment.

In terms of revenue, this research report indicated that the global Contrast Agents market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Contrast Agents industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

The Bayer aims at producing XX K Units Contrast Agents in 2020, with XX % production to take place in global market, GE Healthcare accounts for a volume share of XX %.

Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Contrast Agents Market Include by
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Contrast Agents Market
Bayer
GE Healthcare
Bracco Imaging S.p.A
Guerbet Group
Hengrui Medicine
YRPG
Lantheus Medical Imaging
BeiLu Pharmaceutical

Major Type of Contrast Agents Covered in Research report:
High Density Contrast Agents
Low Density Contrast Agents
Application Segments Covered in Research Market
X-CT
MRI
Application 3

For any other requirements, please feel free to contact us and we will provide you customized report.
With tables and figures helping analyze worldwide (Post pandemic Era) Global Contrast Agents market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Global Contrast Agents Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate

1 Market Scope
1.1 Product Details and Introduction
1.1.1 High Density Contrast Agents -Product Introduction and Major Manufacturers
1.1.2 Low Density Contrast Agents -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

2 Global Contrast Agents Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)

3 Regional Market Analysis
3.1 China Contrast Agents Market
3.1.1 Top Companies leading Contrast Agents Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Contrast Agents Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Contrast Agents Market
3.2.1 Top Companies leading Contrast Agents Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Contrast Agents Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Contrast Agents Market
3.3.1 Top Companies leading Contrast Agents Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Contrast Agents Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Contrast Agents Market
3.4.1 Top Companies leading Contrast Agents Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Contrast Agents Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Contrast Agents Market
3.5.1 Top Companies leading Contrast Agents Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Contrast Agents Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Contrast Agents Market
3.6.1 Top Companies leading Contrast Agents Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Contrast Agents Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Contrast Agents Market
3.7.1 Top Companies leading Contrast Agents Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Contrast Agents Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)

4 Value Chain (Impact of COVID-19)
4.1 Contrast Agents Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Contrast Agents Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors

5 Regional Market Forecast (2021-2027)
5.1 Global Contrast Agents Sales and Growth Rate (2021-2027)
5.2 Global Contrast Agents Sales Value and Growth Rate (2021-2027)

6 Contrast Agents Competitive Analysis
6.1 Bayer
6.1.1 Bayer Company Profiles
6.1.2 Bayer Product Introduction
6.1.3 Bayer Contrast Agents Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 GE Healthcare
6.2.1 GE Healthcare Company Profiles
6.2.2 GE Healthcare Product Introduction
6.2.3 GE Healthcare Contrast Agents Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Bracco Imaging S.p.A
6.3.1 Bracco Imaging S.p.A Company Profiles
6.3.2 Bracco Imaging S.p.A Product Introduction
6.3.3 Bracco Imaging S.p.A Contrast Agents Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Guerbet Group
6.4.1 Guerbet Group Company Profiles
6.4.2 Guerbet Group Product Introduction
6.4.3 Guerbet Group Contrast Agents Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Hengrui Medicine
6.5.1 Hengrui Medicine Company Profiles
6.5.2 Hengrui Medicine Product Introduction
6.5.3 Hengrui Medicine Contrast Agents Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 YRPG
6.6.1 YRPG Company Profiles
6.6.2 YRPG Product Introduction
6.6.3 YRPG Contrast Agents Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Lantheus Medical Imaging
6.7.1 Lantheus Medical Imaging Company Profiles
6.7.2 Lantheus Medical Imaging Product Introduction
6.7.3 Lantheus Medical Imaging Contrast Agents Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 BeiLu Pharmaceutical
6.8.1 BeiLu Pharmaceutical Company Profiles
6.8.2 BeiLu Pharmaceutical Product Introduction
6.8.3 BeiLu Pharmaceutical Contrast Agents Production, Revenue (2016-2021)
6.8.4 SWOT Analysis

7 Conclusion
The (Post pandemic Era) Global Contrast Agents Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

Report Objectives / Segmentation Covered :

By Companies / players:
By Regions:
By Type:
By Application:

Frequently asked questions(FAQ's):

What trends are influencing the growth of the (Post pandemic Era) Global Contrast Agents Market?

New players are entering the (Post pandemic Era) Global Contrast Agents Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.

What is the current state of the (Post pandemic Era) Global Contrast Agents Industry, and what is the projected growth trajectory through 2030?

In 2024, the (Post pandemic Era) Global Contrast Agents Market share surpassed USD xx million, and between 2025 and 2030, it will grow at a CAGR of yy%.

What does the future hold for the (Post pandemic Era) Global Contrast Agents Market?

As the shift to value addition continues, companies in the (Post pandemic Era) Global Contrast Agents Market face the dual challenge of improving interoperability to optimize performance and experience.

What is the CAGR at which the (Post pandemic Era) Global Contrast Agents Market can expand?

During the forecast years, the (Post pandemic Era) Global Contrast Agents Market can thrive with a robust CAGR.